Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

In patients with mild asthma, as-needed use of an inhaled glucocorticoid plus a fast-acting β2-agonist may be an alternative to conventional treatment strategies.

Related collections

Author and article information

Journal

Title: New England Journal of Medicine

Abbreviated Title: N Engl J Med

Publisher: New England Journal of Medicine (NEJM/MMS)

ISSN (Print): 0028-4793

ISSN (Electronic): 1533-4406

Publication date Created: May 17 2018

Publication date (Print): May 17 2018

Volume: 378

Issue: 20

Pages: 1865-1876

Affiliations

[1 ]From the Firestone Institute for Respiratory Health, St. Joseph’s Healthcare and Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON (P.M.O.), and the Institute for Heart and Lung Health, University of British Columbia, Vancouver (J.M.F.) — both in Canada; the Division of Pulmonology, Department of Medicine, University of Cape Town, Cape Town, South Africa (E.D.B.); Airway Disease Section, National Heart and Lung Institute, Imperial College, London (P.J.B.);...

Article

DOI: 10.1056/NEJMoa1715274

PubMed ID: 29768149

SO-VID: f2d86286-5085-4900-9422-9a7cd71392c6

History

Data availability:

Comments

Comment on this article

scite_

Cited by 184

See all cited by

- Version 1